Trevena
TRVN
#11369
Rank
$0 M
Marketcap
$0.0005000
Share price
0.00%
Change (1 day)
-95.00%
Change (1 year)

P/S ratio for Trevena (TRVN)

P/S ratio as of November 2026 (TTM): 0.0008

According to Trevena's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.0000. At the end of 2024 the company had a P/S ratio of 6.22.

P/S ratio history for Trevena from 2014 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246.2277.33%
20233.51
2022N/A-100%
202116951.49%
2020112-95.63%
2019> 100041281.99%
20186.18
2017N/A-100%
201682.1-3.85%
201585.3
2014N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Amgen
AMGN
6.17 781,768.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.04 638,521.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
63.1 7,993,976.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
22.4 2,836,909.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
1.14 143,862.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA